Dose-escalation Study of CX-3543 in Patients With Advanced Solid Tumors or Lymphomas
Clinical trial NCT00955786 · COMPLETED
Trial details
- NCT number
- NCT00955786
- Sponsor
- Cylene Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Primary completion
- 2007-07-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.